Warning: The NCBI web site requires JavaScript to function. more...
The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.
Provan SA, Angel K, Odegård S, Mowinckel P, Atar D, Kvien TK.
Arthritis Res Ther. 2008;10(3):R70. Epub 2008 Jun 23.
Related citations
Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.
Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM.
Arthritis Rheum. 2008 Sep;58(9):2662-9.
NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study.
Provan S, Angel K, Semb AG, Atar D, Kvien TK.
Ann Rheum Dis. 2010 Nov;69(11):1946-50. Epub 2010 Jun 4.
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.
JAMA. 2005 Apr 6;293(13):1609-16.
Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
Peters MJ, Welsh P, McInnes IB, Wolbink G, Dijkmans BA, Sattar N, Nurmohamed MT.
Ann Rheum Dis. 2010 Jul;69(7):1281-5. Epub 2009 Nov 23.
Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis.
Targońska-Stępniak B, Majdan M.
Clin Rheumatol. 2011 Jan;30(1):61-9. Epub 2010 Nov 26.
Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A, Falkensammer G, Alber H, Kroiss A, Griesmacher A, Ulmer H, Pachinger O, Mair J.
Heart. 2009 Feb;95(4):297-303. Epub 2008 Aug 15.
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Ruff CT, Morrow DA, Jarolim P, Ren F, Contant CF, Kaur A, Curtis SP, Laine L, Cannon CP, Brune K.
J Rheumatol. 2011 Jun;38(6):1071-8. Epub 2011 Apr 1.
Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
Coron Artery Dis. 2009 May;20(3):219-24.
Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
Dai DF, Hwang JJ, Lin JL, Lin JW, Hsu CN, Lin CM, Chiang FT, Lai LP, Hsu KL, Tseng CD, Tseng YZ.
Circ J. 2008 Aug;72(8):1316-23.
Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH.
Diabetologia. 2006 Oct;49(10):2256-62. Epub 2006 Aug 26.
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S; LIPID Study Investigators.
Eur Heart J. 2008 Apr;29(7):923-31. Epub 2008 Feb 22.
N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
Guo Q, Bárány P, Qureshi AR, Snaedal S, Heimburger O, Stenvinkel P, Lindholm B, Axelsson J.
Am J Nephrol. 2009;29(6):516-23. Epub 2008 Dec 12.
Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study.
Mueller T, Dieplinger B, Poelz W, Endler G, Wagner OF, Haltmayer M.
Clin Chem. 2009 Jan;55(1):68-77. Epub 2008 Nov 6.
Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
Rothenbacher D, Koenig W, Brenner H.
Arch Intern Med. 2006 Dec 11-25;166(22):2455-60.
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.
Gutiérrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, Januzzi JL, Chang Y, Thadhani R.
Clin Chem. 2008 Aug;54(8):1339-48. Epub 2008 Jun 6.
Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H.
Clin Endocrinol (Oxf). 2005 Nov;63(5):493-8.
Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study.
Jacobs LH, van de Kerkhof JJ, Mingels AM, Passos VL, Kleijnen VW, Mazairac AH, van der Sande FM, Wodzig WK, Konings CJ, Leunissen KM, van Dieijen-Visser MP, Kooman JP.
Nephrol Dial Transplant. 2010 Jan;25(1):243-8. Epub 2009 Aug 19.
Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
Lajer M, Tarnow L, Jorsal A, Parving HH.
Nephrol Dial Transplant. 2007 Nov;22(11):3235-9. Epub 2007 Jun 13.
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.
J Hypertens. 2008 Jan;26(1):26-34.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on